A recent article in the Boston Business Journal notes that the FDA is considering Sunovion Pharmaceuticals Inc.’s requests to approve recent drug Latuda for use in treating bipolar disorder.
Currently, Latuda is only approved for the treatment of schizophrenia, but one application is requesting it be approved to be used in conjunction with other medications to treat bipolar disorder, and another application requests it be approved to treat bipolar disorder alone.
If you aren’t familiar with Latuda (Lurasidone), it is an atypical psychotic approved by the FDA for the treatment of schizophrenia in 2010.
Looking at the list of side effects, they look comparable to those of Geodon (which I just started recently). Side effects range from things like uncontrollable muscle movements, insomnia, nausea, drowsiness, and agitation.
I know this drug has not actually been approved by the FDA for bipolar disorder yet, but I do know one or two people that have been taking it for bipolar symptoms. For those of us who have symptoms bordering on schizophrenia (or schizoaffective disorder) or for those who haven’t been able to tolerate other atypical antipsychotics (like abilify, zyprexa, or geodon) it is always great to hear that there may soon be another option out there!